115
Participants
Start Date
May 27, 2020
Primary Completion Date
December 31, 2024
Study Completion Date
June 30, 2025
ICP-192
ICP-192 is a white, round, uncoated table
RECRUITING
Peking University First Hospital, Beijing
RECRUITING
The fifth Medical Center of People's Liberation Army General Hospital, Beijing
RECRUITING
Beijing Cancer Hospital, Beijing
RECRUITING
Liaoning Cancer Hospital & Institute, Shenyang
RECRUITING
The First Hospital of JiLin University, Jilin
RECRUITING
Harbin Medical University Cancer Hospital, Harbin
RECRUITING
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
RECRUITING
The First Affiliated Hospital of Suzhou University, Suzhou
RECRUITING
The First Affiliated Hospital of Anhui Medical University, Hefei
RECRUITING
Shandong University Qilu Hospital, Jinan
RECRUITING
Tianjin Medical University Cancer Institute & Hospital, Tianjin
RECRUITING
The Second Hospital of Tianjin Medical University, Tianjin
RECRUITING
The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
RECRUITING
Zhejiang Provincial People's Hospital, Hangzhou
RECRUITING
Zhejiang Cancer Hospital, Hangzhou
RECRUITING
The First Affiliated Hospital of Chongqing Medical University, Chongqing
RECRUITING
Hunan Cancer Hospital, Changsha
RECRUITING
Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan
RECRUITING
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan
RECRUITING
Sichuan Cancer Hospital, Chengdu
RECRUITING
Lanzhou University Second Hospital, Lanzhou
RECRUITING
First Hospital of Shanxi Medical University, Taiyuan
Beijing InnoCare Pharma Tech Co., Ltd.
INDUSTRY